Opportunity ID: 60733

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-12-001
Funding Opportunity Title: New Molecular Entities to Treat Substance Use Disorders (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 22, 2010
Last Updated Date:
Original Closing Date for Applications: Mar 17, 2011
Current Closing Date for Applications: Mar 17, 2011
Archive Date: Apr 17, 2011
Estimated Total Program Funding: $2,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
County governments
Public and State controlled institutions of higher education
City or township governments
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
State governments
Native American tribal governments (Federally recognized)
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications for preclinical research projects that can be conducted with accelerated pace from the drug discovery stage to the early development stage, with the ultimate goal of identifying new molecular entities (NME) as candidate compounds and moving them closer to gaining FDA approval of safe and efficacious medications for the treatment of substance use disorders (SUDs).
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-12-001.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.279 ADOBE-FORMS-B1 Adobe-Forms-B1 PKG00024070 Feb 17, 2011 Mar 17, 2011 View

Package 1

Mandatory forms

60733 RR_SF424_1_2-1.2.pdf

60733 RR_OtherProjectInfo_1_3-1.3.pdf

60733 RR_KeyPersonExpanded_1_2-1.2.pdf

60733 PerformanceSite_1_4-1.4.pdf

60733 PHS398_ResearchPlan_1_3-1.3.pdf

60733 PHS398_CoverPageSupplement_1_4-1.4.pdf

60733 PHS398_Checklist_1_3-1.3.pdf

Optional forms

60733 RR_Budget-1.1.pdf

60733 RR_SubawardBudget-1.2.pdf

60733 PHS_CoverLetter_1_2-1.2.pdf

60733 PHS398_ModularBudget-1.1.pdf

2025-07-12T11:30:10-05:00

Share This Post, Choose Your Platform!

About the Author: